FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

30011111000001100: Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93783901000001113 Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93784001000001111 Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet Is a Cefuroxime 250mg tablets 14 tablet true Inferred relationship Existential restriction modifier
Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet Has AMP Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet Has specific active ingredient Cefuroxime axetil true Inferred relationship Existential restriction modifier
Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cefuroxime true Inferred relationship Existential restriction modifier
Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Cefuroxime 250mg tablets (Mawdsley-Brooks & Company Ltd) 14 tablet Has basis of strength substance Cefuroxime true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start